Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility, Double Blind, Placebo-controlled Clinical Study Designed to Evaluate the Effect of 'Encer' on Cancer Treatment Related Fatigue

NCT07707648 is registered in ClinicalTrials.gov with Beaura for Para Pharmaceutical Products Trading LLC as lead sponsor.

NCT NCT07707648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07707648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility, Double Blind, Placebo-controlled Clinical Study Designed to Evaluate the Effect of 'Encer' on Cancer Treatment Related Fatigue
Lead sponsor
Beaura for Para Pharmaceutical Products Trading LLC
Phase
Phase 1
Overall status
Recruiting
Start date
October 1, 2025
Completion date
October 31, 2026
Enrollment
74 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue related to cancer treatment